Heghine Khachatryan: Balancing Thrombosis and Bleeding Risks in Acute Leukemia
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared Seminars in Thrombosis and Hemostasis‘ post on LinkedIn about a recent article by Shay Perek et al., published in Seminars in Thrombosis and Hemostasis, adding:
“Balancing Thrombosis and Bleeding Risks in Acute Leukemia
Managing catheter-related thrombosis in patients with acute leukemia remains a significant clinical challenge, particularly in the presence of severe thrombocytopenia.
A recent study by Perek et al., published in Seminars in Thrombosis and Hemostasis, provides valuable real-world evidence on a platelet-count-guided low-molecular-weight heparin (LMWH) strategy.
The findings highlight the potential role of individualized anticoagulation in this particularly vulnerable patient population.
Importantly, the absence of statistically significant differences in clinical outcomes should not be interpreted as evidence of therapeutic equivalence, given the observational nature of the study.
The key clinical message is clear: anticoagulation decisions should integrate platelet counts, thrombotic risk, bleeding risk, and the individual clinical context.
Further prospective studies are essential to establish optimal management strategies.
Congratulations to the authors for addressing this important clinical challenge.”
Seminars in Thrombosis and Hemostasis shared a post on LinkedIn:
“Managing catheter-related thrombosis in patients with acute leukemia presents a unique clinical challenge, especially when thrombocytopenia limits anticoagulation options.
A new study in Seminars in Thrombosis and Hemostasis evaluates a platelet-count-guided low molecular weight heparin (LMWH) strategy for the management of catheter-related thrombosis in a large cohort of patients with newly diagnosed acute leukemia, providing important real-world evidence for balancing thrombosis and bleeding risks.”
Title: Platelet-Count-Guided Low Molecular Weight Heparin Management of Catheter-Related Thrombosis in a Large Cohort of Patients with Newly Diagnosed Acute Leukemia
Authors: Shay Perek, Niv Izhaki, Ron Hoffman, Benjamin Brenner, Netanel A. Horowitz
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Nov 10, 2026, 09:38How Hydroxyurea Affects Ovarian Reserve in Girls and Women with SCD – ASH Education
-
Nov 10, 2026, 08:43Rufiga Shari Abidin: Multi Organ Complications Detailed in COVID 19 Vaccine Adverse Event Study
-
Nov 10, 2026, 08:36Bahram Alamdary Badlou: Why Jak Inhibitors Demand Careful Monitoring In Chronic Inflammation Treatment?
-
Nov 10, 2026, 08:16Uyiekpen Ima-Edomwonyi: Why Autoimmune Inflammation Demands Early Vigilance?
-
Nov 10, 2026, 06:20Vida Shafti: Can AI Help Us Predict Thrombosis before it Happens in Assisted Reproduction?
-
Nov 10, 2026, 06:11Michaël Prüfer: Treatment of Varicose Veins with Laser Endoveineux Total
-
Nov 10, 2026, 05:55Sandhya Selvakumar: Guide to Stroke Classification and Rehabilitation
-
Nov 9, 2026, 22:47Avirup Guha: Early Immune Responses to Androgen Deprivation Therapy and Coronary Plaque Progression
-
Nov 9, 2026, 22:42Angela Forsyth: Joining Novo Nordisk as Medical Liaison for the Ohio Valley Region